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a b s t r a c t
Marek’s disease virus (MDV) is a lymphotropic alphaherpesvirus that replicates in a highly cell-
associated manner in vitro. Production of infectious cell-free virus only occurs in feather follicle
epithelial (FFE) cells of infected chicken skins. Previously, we described differential expression for a
core alphaherpesvirus protein, pUL47 that was found to be abundantly expressed in FFE cells of infected
chickens, while barely detectable during in vitro propagation. Here, we further examined the dynamics
of expression of four tegument proteins within the UL46–49 locus during in vitro and in situ replication.
All four proteins examined were expressed abundantly in situ, whereas both pUL47 and pUL48
expression were barely detectable in vitro. Replacement of the putative UL47 and UL48 promoters with
the minimal cytomegalovirus promoter enhanced mRNA and protein expression in vitro. Interestingly,
enhanced expression of pUL47 resulted in increased UL46, UL48, and UL49 transcripts that resulted in
increased pUL46 and pUL48 expression.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Marek’s disease (MD) in chickens is caused by the alphaher-
pesvirus gallid herpesvirus type 2 (GaHV-2) or MD virus (MDV)
resulting in signiﬁcant disease in chickens, in particular the
development of solid lymphomas in the viscera and other organs
(Calnek, 2001; Jarosinski et al., 2006). Infection with MDV begins
through the respiratory route by inhalation of infectious virus
previously shed from infected chickens. Virus is thought to be
taken up by pulmonary immune cells and transported to lymphoid
organs, where primary cytolytic infection occurs in B lymphocytes.
MDV then infects activated T lymphocytes where it can establish
latency, primarily in CD4þ T cells, which can also undergo
oncogenic transformation ultimately resulting in lymphoma for-
mation and death of the chicken. It is hypothesized that, as
described for human varicella zoster virus (VZV) (Ku et al.,
2002), migrating lymphocytes also transport MDV to the skin,
where infectious virus is produced in feather follicle epithelial
(FFE) cells and, essential for dissemination of the virus, shed into
the environment. MDV is highly cell-associated in tissue culture
cells and during in vivo replication in B and T lymphocytes (Ahmed
and Schidlovsky, 1968; Churchill and Biggs, 1967; Solomon et al.,
1968), while the only known cell type believed to facilitate fully
infectious cell-free virus production are FFE cells in the skin
(Calnek et al., 1970).
Herpesviruses are composed of four structural elements, a core
containing the double-stranded DNA genome, an icosahedral
capsid harboring the core, a proteinaceous layer called the tegu-
ment that immediately surrounds the capsid, and an envelope
containing viral membrane (glyco)proteins (Pellett and Roizman,
2007). In the case of herpes simplex virus type 1 (HSV-1), the
prototypic alphaherpesvirus, the tegument is composed of
approximately 20 viral proteins that perform both structural and
regulatory roles during viral infection (Mettenleiter, 2004;
Roizman et al., 2007). These proteins enter the host cell as part
of the virion and regulate a number of essential functions during
the initial phases of infection such as targeting of virion compo-
nents to the nucleus, initiation of viral transcription, and regula-
tion of viral and cellular transcription and translation. Newly
synthesized tegument protein also participate in assembly of
virions during egress (Kelly et al., 2009). Tegument protein genes
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may either be highly conserved in Herpesviridae, displaying similar
regulatory or structural functions, or conserved as a gene cluster
such as the UL46–UL49 cluster found only in the Alphaherpesvir-
inae in which they were identiﬁed as major components of the
virion.
The open reading frame (ORF) UL46 encodes pUL46 (VP11/12),
an abundant phosphorylated tegument protein in HSV-1 particles
(Heine et al., 1974; Kato et al., 2000; Lemaster and Roizman, 1980;
Willard, 2002; Zhang and McKnight, 1993) which is dispensable
for replication of HSV-1, pseudorabies virus (PRV), VZV, and MDV
in vitro (Che et al., 2008; Dorange et al., 2002; Fuchs et al., 2003;
Zhang and McKnight, 1993). Little is known about the function of
pUL46 during herpesvirus replication, but it has been ascribed to
playing an important role in enhancing trans-activation of
immediate early (IE) genes (Kato et al., 2000; Zhang and
McKnight, 1993; Zhang et al., 1991). HSV-1 pUL46 is normally
localized within the cytoplasm with punctate characteristics dur-
ing in vitro replication and has a high association with capsids
(Brignati et al., 2003; Kato et al., 2000; Murata et al., 2000;
Murphy et al., 2008; Nozawa et al., 2004; Willard, 2002).
UL47 encodes pUL47 (VP13/14), which represents differently
processed forms of the primary translation product (Meredith et
al., 1991; Whittaker et al., 1991) and has been shown to be
important, but not essential, for replication of most alphaherpes-
viruses examined thus far, including HSV-1, PRV, infectious lar-
yngotracheitis virus (ILTV), bovine herpesvirus (BoHV-1), and MDV
in tissue culture (Dorange et al., 2002; Helferich et al., 2007; Kopp
et al., 2002; Lobanov et al., 2010; Zhang et al., 1991). Interestingly,
pUL47 (ORF11), although being dispensable for replication of VZV
in vitro (Che et al., 2008) is an important determinant for VZV
virulence in differentiated epidermal skin cells (Che et al., 2011,
2008). Similar results were observed for a UL47-null mutant of
ILTV which was severely attenuated in chickens, whereas little
attenuation was seen during in vitro replication (Helferich et al.,
2007). The tegument protein has been shown to bind RNA and it is
believed to shuttle RNA molecules between the cytoplasm and
nucleus (Donnelly and Elliott, 2001b). Most recently, it was shown
to also play a role in regulating selective degradation of mRNA by
the virion host shutoff (VHS) RNase of HSV-1 (Shu et al., 2013) and
regulating viral nuclear egress through interactions with UL31,
UL34, and US3 (Liu et al., 2014). Localization of pUL47 in cells is
primarily nuclear for the case of HSV-1 and MDV in vitro (Donnelly
and Elliott, 2001b; Dorange et al., 2000; Jarosinski et al., 2012;
Yedowitz et al., 2005), while Che et al. (2011) found VZV VP13/14
(ORF11) to be both cytoplasmic and nuclear. In an earlier report,
the localization of MDV pUL47 was found to be expressed at very
low levels and predominantly nuclear in infected chick kidney cell
cultures, while it was abundantly expressed in FFE cells where it
localized primarily to the cytoplasm (Jarosinski et al., 2012).
pUL48, is also known as α-transinducing factor (α-TIF) or VP16,
and is both a regulatory and a structural protein that is required
for lytic infection of most alphaherpesviruses studied to date
(Fuchs et al., 2002, 2003; von Einem et al., 2006; Weinheimer et
al., 1992), with the exception of MDV and VZV (Che et al., 2006;
Dorange et al., 2002). pUL48 initiates IE transcription by formation
of the pUL48-induced transcription complex in the nucleus that
includes host cell factor 1 (HCF-1) and Oct-1 (Gerster and Roeder,
1988; Herr, 1998; Stern et al., 1989; Wysocka and Herr, 2003).
Transcriptional activity of pUL48 has been shown to be enhanced
by tegument proteins pUL46 and pUL47, potentially through direct
interactions (Vittone et al., 2005; Zhang and McKnight, 1993;
Zhang et al., 1991). pUL48 has been shown to play a central role
in HSV-1 egress and the formation of mature virions (Mossman et
al., 2000; Weinheimer et al., 1992). In the case of MDV and VZV,
deletion of UL48 or ORF10, respectively, resulted in no effect
during in vitro replication; however, a severe deﬁciency in virion
formation and cell-to-cell spread was reported for VZV ORF10-null
mutant using the SCIDhu mice model for VZV infection (Che et al.,
2006). HSV-1 pUL48 is localized to both the cytoplasm and
nucleus early during infection of Vero cells, but becomes mostly
cytoplasmic at later times (Elliott et al., 1995). Expression of MDV
pUL48 was formerly found to be barely detectable in infected cells
using a monoclonal antibody (mAb) against the viral protein
(Dorange et al., 2000).
pUL49 (VP22) has been shown to represent a major tegument
protein for most Alphaherpesvirinae. Conversely to pUL48, VP22 is
indispensable for replication of MDV (UL49) and VZV (ORF9) (Che
et al., 2008; Dorange et al., 2002), whereas pUL49 is dispensable
for HSV-1, PRV, and BoHV-1 in cell culture (del Rio et al., 2002;
Elliott et al., 2005; Kalthoff et al., 2008; Liang et al., 1997). The
exact role of pUL49 in MDV replication is not known, but recently
has been linked to cell cycle modulation by triggering S-phase
arrest and DNA damage in infected cells (Trapp-Fragnet et al.,
2014). pUL49 homologues in HSV-1 and VZV have been linked to
recruitment of other tegument proteins and interaction with
glycoproteins, resulting in efﬁcient virus egress and cell-to-cell
spread (Cilloniz et al., 2007; Duffy et al., 2006; Elliott et al., 2005).
More recently, it has been shown that pUL49 interacts with pUL48
and VHS directly to form a tripartite complex (Taddeo et al., 2007)
and that pUL49 might play a role in regulating mRNA abundance
and protein translation at late times of infection (Mbong et al.,
2012). pUL49 has also been shown to regulate translocation of
other viral proteins during infection, including pUL48 (Tanaka et
al., 2012). In vivo, a knock out mutant of UL49 in BoHV-1 displayed
a dramatically reduced virulence for its host (Liang et al., 1997).
Localization of pUL49 is predominantly in the cytoplasm of
infected cells, but a proportion of the protein can be found in
the nucleus at late times of HSV-1 infection (Donnelly and Elliott,
2001a; Hutchinson et al., 2002). Similar results have been shown
during MDV replication in vitro (Blondeau et al., 2008; Denesvre
et al., 2007; Jarosinski et al., 2012).
Many aspects of MDV replication and pathogenesis have
remained unknown, partly due to the inability to produce sufﬁ-
cient amounts of cell-free virus in vitro, and up until about a
decade ago, a lack of efﬁcient recombinant (r) DNA technologies
needed to address speciﬁc questions in replication and pathogen-
esis. Furthermore, for UL46-49 gene cluster proteins, as well as for
other structural proteins, even though proteins may display
conserved functions delineated in replacement studies (58), spe-
ciﬁc roles for these proteins may not be extrapolated from studies
on HSV-1 or PRV. We have recently developed rMDV in which
pUL47 was tagged with ﬂuorescent proteins (Jarosinski, 2012a,
2012b; Jarosinski et al., 2012). In these reports, two important
ﬁndings were noted. First, fusion of enhanced green ﬂuorescent
protein (eGFP) or monomeric red ﬂuorescent protein (mRFP)
genes to the C-terminus of UL47 resulted in no change in
pathogenicity in chickens. Second, very little pUL47eGFP could
be detected in vitro, while, in contrast, expression of pUL47eGFP in
FFE cells of infected chickens was abundant. In an earlier report,
we showed that MDV tegument proteins encoded by the UL46–
UL49 gene cluster varied dramatically in their expression in
infected cell cultures, but in situ expression of those proteins
was not studied (Dorange et al., 2000). Here, we asked the
question of whether this discrepancy between “in vitro” and
“in situ” expression could be observed for the remaining viral
proteins within the UL46–49 gene cluster and whether their
expression could be a cause or marker of complete assembly of
MDV leading to fully productive infection.
In this study, we expanded our analysis of differential viral gene
expression of pUL46, pUL47, pUL48, and pUL49 by comparing
in vitro and in situ expression and localization of viral proteins.
Consistent with our former studies (Dorange et al., 2000;
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Jarosinski et al., 2012), pUL47 and pUL48 were expressed at very
low levels, while pUL46 and pUL49 were expressed to moderate
and high levels in vitro, relative to overall MDV protein expression.
In vivo, there was no such discrepancy in expression for pUL46,
pUL47, pUL48, and pUL49. As we hypothesized that inefﬁcient
expression in cell culture might be related to a low activation of
endogenous viral promoters, we individually replaced the putative
promoters of UL47 (PUL47) and UL48 (PUL48) with the cytomegalo-
virus (CMV) immediate early minimal promoter (PCMV). Expression
of each viral protein was then examined in vitro and in situ. Our
data showed that (i) differential expression of tegument proteins
pUL47 and pUL48 is presumably due to activation of endogenous
promoters by cellular factors in the highly differentiated FFE cells,
(ii) individual augmentation of expression of pUL47 or pUL48 did
not alleviate “incomplete morphogenesis” in cell culture leading to
cell-free virus production, and (iii) increased pUL47 expression
resulted in increased pUL46 and pUL48 expression, suggesting a
role for MDV pUL47 in regulation of the UL46–UL49 locus in vitro
and in situ.
Results
In vitro and in situ expression of pUL46, pUL47, pUL48, and pUL49
According to our previous results on differential expression of
pUL47 (Jarosinski et al., 2012) and low expression of pUL48 in
infected cell culture (Dorange et al., 2000), we hypothesized that
the low level of MDV pUL47 and pUL48 protein expression during
virus propagation in tissue culture was indicative of a lack of
speciﬁc late gene expression. These late tegument proteins and/or
additional, yet unidentiﬁed, viral proteins might be important for
full virion assembly and their absence could lead to a blockade in
virion morphogenesis (Denesvre et al., 2007). In order to form an
expanded view of viral protein expression both in vitro and in situ,
the expression of pUL46, pUL47, pUL48, and pUL49 was examined
using immunoﬂuorescence (IF) assays in vitro and in situ utilizing
rMDV expressing ﬂuorescently tagged pUL47 (pUL47eGFP) pre-
viously described (Jarosinski et al., 2012).
As a preamble to this series of experiments, we showed that
expression of pUL47eGFP can be clearly seen in situ in FFE cells at
day 21 post-infection (pi), allowing the easy identiﬁcation of
infected cells in vivo (Fig. S1). Next, we set up a quantitative
evaluation in order to better measure the differential expression of
each respective viral protein either in vUL47eGFP-infected chicken
embryo cell (CEC) cultures or in FFE cells from chickens infected
with vUL47eGFP at 21 days pi. For each speciﬁc viral protein
examined, ﬂuorescent signals were adjusted such that the thresh-
old was set below saturation levels without having signiﬁcant
background from uninfected cells. Infected cells were determined
using signal generated from the anti-MDV polyclonal sera. As a
control, ICP4 expression was also evaluated, since it is expressed
during both early and late lytic replication in vitro (Endoh et al.,
1996). Consistent with earlier reports, both pUL47 and pUL48 were
barely visible in infected CEC cultures, while ICP4 and pUL49 were
abundantly expressed (Fig. 1A). pUL46 had not been formerly
studied, but we found its expression to be moderate compared to
ICP4 and pUL49 protein expression. Next, expression of ICP4,
pUL46, pUL47, pUL48, and pUL49 was examined during in situ
replication in FFE cells obtained from MDV-infected chickens
(Fig. 1B). In contrast to in vitro protein expression, all proteins
examined were easily detectable in FFE cells. All genes were
expressed at signiﬁcantly different levels when comparing expres-
sion between in vitro and in situ situations, with ICP4 and pUL49
being expressed higher in vitro, while pUL46, pUL47, and pUL48
were expressed higher in situ (Fig. 1C).
Increased pUL47eGFP and pUL48 in vitro
In order to investigate whether the low level of expression of
pUL47eGFP could be related to the efﬁciency of the viral promoter
of UL47 (PUL47), we replaced the putative endogenous viral
promoter with PCMV (Fig. 2C). A similar strategy was adapted for
the replacement of the UL48 promoter (PUL48) by PCMV in the
backbone of rUL47eGFP (Fig. 2D). Following construction of rMDV
bacterial artiﬁcial chromosome (BAC) clones, restriction fragment
length polymorphism (RFLP) analyses showed no extraneous
alterations in the viral genome, apart from the expected changes
(Fig. 2E).
With both rMDV, enhanced expression of pUL47eGFP and
pUL48 could be observed (Fig. 3A and B), without affecting viral
spread, as indicated by the absence of statistically signiﬁcant
differences in plaque sizes between parental virus (vUL47eGFP)
and vPCMVUL47eGFP or vPCMVUL48 (Fig. 3C).
Next, we wanted to determine whether increased expression of
pUL47eGFP or pUL48 resulted in increased production of cell-free
virus. To do this, we utilized a modiﬁed method for extraction of
cell-free virus previously described (Grose et al., 1979). In order to
test this system with rMDV, we ﬁrst compared levels of cell-free
virus extracted from rVZV, rHVT (turkey herpesvirus), and rMDV
using the same approach. Both VZV and HVT are known to be
highly cell-associated, but cell-free virus can be extracted follow-
ing sonication of infected cells (Calnek et al., 1970; Grose et al.,
1979). Signiﬁcantly higher amounts of cell-free virus were
obtained from vVZV- or vHVT-infected cultures, while vMDV
produced only minimal amounts (Fig. 4A). Next, we measured
the amount of cell-free virus extracted from vRB-1B, vUL47eGFP,
vPCMVUL47eGFP, or vPCMVUL48 and found that increased expres-
sion of pUL47eGFP or pUL48 did not result in increased production
of cell-free virus in three separate experiments (Fig. 4B). Therefore,
the low level of pUL47eGFP or pUL48 are not the sole reason for
inefﬁcient virion assembly in vitro.
Localization of pUL46, pUL47, pUL48, and pUL49 in vitro and in situ
Since expression of pUL47eGFP and pUL48 could be more
readily detected with each virus, high magniﬁcation images were
collected using laser scanning confocal microscopy to evaluate
localization of pUL46, pUL47, pUL48, pUL49, and ICP4 in vitro and
in situ. In vitro localization of ICP4, pUL46, pUL47, and pUL49 was
monitored by using vPCMVUL47eGFP, while vPCMVUL48 was used
for evaluation of pUL48 (Fig. 5A). For localization of viral proteins
in situ, vUL47eGFP-infected FFE cells were used (Fig. 5B).
During in vitro replication, pUL46, pUL48, and pUL49 were
mostly cytoplasmic with some nuclear staining (Fig. 5A). pUL46
and ICP4 were almost exclusively localized separately from
pUL47eGFP with occasional co-localization events observed, while
it appeared there was very little co-localization of pUL49 and
pUL47eGFP. Even in speciﬁc regions in the nuclei where both
proteins were present, they appeared to be exclusive of each other
(noted with white dots). Interestingly, localization of pUL47eGFP
was also seen in cytoplasmic puncta when expression was
enhanced in vitro. This is in contrast to our previous observations
where normal low level expression of pUL47eGFP that could be
detected was mostly nuclear (Jarosinski et al., 2012). Similar
staining of pUL47 was seen for another virus generated in which
non-tagged pUL47 expression was enhanced by PCMV regulation
(data not shown), indicating fusion of eGFP to the C-terminus of
pUL47 had no effect on localization.
In comparison of in vitro to in situ localization of each viral
protein, there did not appear to be obvious differences for pUL46,
pUL48, and pUL49 (Fig. 5A and B). Similar to previous observa-
tions, pUL47eGFP expression was seen in both cytoplasmic and
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nuclear portions and in some punctate forms in FFE cells. ICP4 was
mostly cytoplasmic during in situ replication, which is in contrast
to being both nuclear and cytoplasmic in vitro. Mostly likely this is
due to the stage of infection of FFE cells as they are believed to be
at very late stages of replication at which ICP4 is expected to be
more localized to the cytoplasm, similar to what has been shown
for the VZV ICP4 homologue, IE62 (Booss and Esiri, 2003).
Expression of pUL46, pUL47, pUL48, and pUL49 in vitro following
increased expression of pUL47eGFP or pUL48
Following conﬁrmation that replacement of PUL47 and PUL48
with PCMV resulted in enhanced expression of pUL47eGFP and
pUL48, respectively, we examined expression of pUL46 and pUL49
to determine whether their expression proﬁles were also altered.
Interestingly, expression of pUL46 (Fig. 6A) and pUL48 (Fig. 6B)
were signiﬁcantly increased following enhanced expression of
pUL47eGFP, while pUL46 and pUL47eGFP were unaffected by
increased pUL48 expression (Fig. 6A). Western blot analysis con-
ﬁrmed this effect for pUL47eGFP and pUL48 (Fig. 6D), but for
pUL46, no conﬁrmation could be obtained as the mAb used in this
study did not recognize denatured epitopes.
Late protein expression is not directly related to mRNA expression
in situ
Since the level of pUL47 and pUL48 protein expression was very
low in vitro, while abundant in situ, and we were able to signiﬁcantly
increase their expression by manipulation of their respective pro-
moters, we hypothesized that differential protein expression was
due to differential mRNA transcription for each viral gene. Therefore,
we examined mRNA expression of UL46, UL47, UL48, UL49, and ICP4
as a control using RT-qPCR assays. CEC cultures were infected with
vUL47eGFP and total RNA was collected every day for 6 days. cDNA
was generated using poly dT and speciﬁc primers were used for each
gene (Table S1) and speciﬁc transcript levels were normalized to
quantiﬁed chicken glyceraldehyde-3-phosphate dehydrogenase
(chGAPDH) levels (Fig. 7B). Interestingly, the lowest level of mRNA
produced was for ICP4, while the highest level of mRNA expression
was found for UL48. Relative levels of mRNAwere UL484UL494U-
L474UL464ICP4 per copies of chGAPDH. Similar results were
Fig. 1. MDV pUL47 and pUL48 are abundantly expressed in situ, while only barely detectable during in vitro replication. (A) CEC cultures were infected with vUL47eGFP on
glass coverslips and then ﬁxed at 4 days pi. Plaques were stained for multiple antigens and four color images were taken using the Zeiss LSM-710 confocal microscope using
ZEN2010 software. Shown is a representative plaque for each viral protein examined. Anti-MDV chicken antibody was used to identify overall MDV antigen expression (gray).
Anti-ICP4, -pUL46, -pUL47, -pUL48, or -pUL49 mAbs (red) were used to examine speciﬁc MDV antigen expression. pUL47eGFP (green) was directly detected. Merged images
contain all three ﬂuorescent channels including Hoechst 33342 staining to better identify nuclei (blue). (B) Skin/feather tissues were collected from a vUL47eGFP-infected
chicken at 21 days pi. Slides with tissues were ﬁxed and stained for multiple antigens as in (A). (C) Fluorescent signals were quantitated as described in Materials and
methods section and shown as percent signal relative to total MDV protein expression. The percent expression for ICP4, pUL46, pUL47, pUL48, and pUL49 during in vitro and
in situ replication was compared and statistically differences are shown.
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found using wild-type vRB-1B lacking the C-terminal eGFP tag on
UL47 (data not shown).
Previous reports have suggested that multiple transcripts are
generated from the UL46-UL49 gene locus including a long transcript
including all four ORFs, two transcripts encoding UL46þUL47 and
UL48þUL49, and a single transcript encoding UL46 alone (Yanagida
et al., 1993). Since primers for speciﬁc viral genes could potentially
detect polycistronic mRNAs, we measured the level of mRNAs
ampliﬁed using primer sets spanning intergenic sequences. In contrast
to former Northern blot analyses, the level of mRNA detected
spanning UL46–UL47, UL47–UL48, and UL48–UL49 was minimal
relative to primer sets that amplify cDNA within individual genes
(Fig. S3). Thus, the contribution of polycistronic transcripts to overall
speciﬁc gene expression is most likely minimal. Northern blotting
using digoxigenin (DIG)-labeled probes conﬁrmed overall mRNA
levels encoding UL46, UL47, UL48, and UL49 were abundantly
increased during vPCMVUL47eGFP expression.
Next, expression of UL46, UL47, UL48, UL49, and ICP4 tran-
scripts were quantitated from three feather follicles obtained from
one chicken infected with vUL47eGFP at 21 days pi. Similarly to
protein expression in FFE cells (Fig. 1B), the average transcripts for
each viral gene were abundantly expressed with over 3 logs higher
levels of mRNA expression relative to chGADPH copies (Fig. 7C).
Most likely this large difference is the result of selectively collect-
ing only infected FFE cells from feather follicles, while RNA
collected from infected CEC cultures contains more uninfected
cells affecting the viral to host gene transcript ratio. Interestingly,
the relative levels of each speciﬁc transcript to each other was
similar with that seen in CEC cultures with UL484UL474U-
L494 ICP44UL46. These data suggest that abundance of speciﬁc
Fig. 2. Generation of rMDV expressing enhanced pUL47eGFP and pUL48 levels. (A) Schematic representation of the MDV genome depicting the locations of the terminal
repeat long (TRL) and short (TRS), internal repeat long (IRL) and short (IRS), and unique long (UL) and short (US) regions. (B) The positions and orientations of the UL46
through UL49 genes with putative promoters within the UL for rUL47eGFP that has been previously published (Jarosinski et al., 2012). (C) Schematic representation of
rPCMVUL47eGFP in which PUL47 was replaced with PCMV. (D) Schematic representation of rPUL48 in which PUL48 was replaced with PCMV. (E) The left panel shows RFLP analysis
of BAC DNA obtained for rUL47eGFP and one rMDV clone of rPCMVUL47eGFP showing integrated (PCMVUL47eGFPþKan) and resolved ﬁnal clone (rPCMVUL47eGFP) digested
with BamHI to conﬁrm the expected band shift patterns (indicated with arrows). The replacement of PUL47 with PCMV results in shifts of band sizes from 18,748 (rUL47eGFP)
to 20,240 (rPCMVUL47eGFPþKan) to 19,206 (rPCMVUL47eGFP). No extraneous alterations are evident. The molecular weight marker used was the 1 kb Plus DNA Ladder from
Invitrogen, Inc. (Carlsbad, CA). The right panel shows RFLP analysis of BAC DNA obtained from rUL47eGFP and one rMDV clone of rPCMVUL48 showing the integrated
(PCMVUL48þKan) and ﬁnal resolved clone (rPCMVUL48) digested with BamHI. The replacement of PUL48 with PCMV results in shifts of band sizes from 18,748 (rUL47eGFP) to
20,325 (rPCMVUL48þKan) to 19,347 (rPCMVUL48). No extraneous alterations are evident.
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viral transcripts, at least in vitro, does not directly correlate with
viral protein expression in vitro.
Since we observed signiﬁcant increases in pUL47eGFP and
pUL48 by replacement of their respective putative promoters with
PCMV, we hypothesized that the increased expression of protein
was due to increased mRNA transcription. Therefore, we deter-
mined mRNA levels of UL46, UL47, UL48, and UL49 in vUL47eGFP-,
vPCMVUL47eGFP-, and vPCMVUL48-infected CEC cultures daily over
6 days. We also included analysis of another gene, UL44 (gC),
located downstream of the UL46-UL49 locus as a control. Con-
sistent with Northern blotting data (Fig. S3), insertion of PCMV in
front of the UL47 gene resulted in increased transcription of not
only UL47eGFP (Fig. 8D), but also UL46 (Fig. 8C), UL48 (Fig. 8E),
and UL49 (Fig. 8F). Insertion of PCMV in front of UL48 only resulted
in signiﬁcantly increased expression of UL48 (Fig. 8E). As seen in
our initial measurement of late gene transcription (Fig. 7B), the
number of transcripts of UL46-UL49 was very high relative to ICP4.
Expression of UL44 was unaffected by insertion of PCMV upstream
of UL47 or UL48, suggesting the enhanced mRNA expression
directly due to PCMV was limited to those four genes (UL46–49).
These data suggest that low level protein expression of pUL47 and
pUL48 in vitro during MDV replication is not solely related to
mRNA transcription of each gene, but other factors such as
translational efﬁciency, protein function, or stability are also most
likely important in the regulation of UL46–UL49 gene locus.
Discussion
In this report, we extended our investigations on the differ-
ential expression of late viral tegument proteins in CEC cultures
(in vitro) compared to FFE cells of infected chickens (in situ). We
previously reported that pUL47, a late phase tegument protein,
was expressed to higher levels in FFE cells (Jarosinski et al., 2012);
known to be the only site of “complete” assembly of MDV virions.
pUL47 is a member of the alphaherpesvirus speciﬁc tegument
protein gene cluster UL46 to UL49. We have also reported on the
low level of synthesis of pUL48 in CEC cultures, whereas the
remaining other proteins (pUL46 and pUL49) within this locus
were readily detectable using mAb in western blot analyses
(Dorange et al., 2000). Therefore we were initially interested at
monitoring the expression of these four proteins in the CEC
cultures and FFE cells to determine whether differential expres-
sion occurred for all proteins in this cluster. By using either direct
Fig. 3. Increased pUL47eGFP and pUL48 does not affect rMDV growth in vitro. (A) CEC cultures infected with vUL47eGFP or vPCMVUL47eGFP were ﬁxed at 5 days pi and
stained with anti-MDV polyclonal sera and anti-chicken IgY Alexa 633 secondary antibody (gray). Merged images include Hoechst 33342 stain for visualization of nuclei.
Expression of pUL47eGFP (green) could be easily detected when expressed under PCMV control. (B) CEC cultures infected with vUL47eGFP or vPCMVUL48 were ﬁxed at 5 days
pi and dual stained with anti-MDV polyclonal sera and mAb against pUL48 plus secondary antibodies anti-chicken IgY Alexa 633 (gray) and anti-mouse IgG Alexa 568 (red).
Merged images include Hoechst 33342 stain for visualization of nuclei. Expression of pUL48 is increased under PCMV control. (C) Plaque areas were measured for vUL47eGFP,
vPCMVUL47eGFP, and vPCMVUL48. No differences were seen between all three viruses using Student’s t tests.
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(tagged viral proteins) or indirect probes (mAbs) we found that
pUL47, pUL48 and, to a lesser degree, pUL46 were expressed to a
higher level in FFE compared with CEC cultures when protein
levels were compared to overall MDV protein expression (Fig. 1).
This feature was not shared by pUL49, which was expressed at
higher levels in vitro. It seems noteworthy that detection by mAbs
matched closely the direct detection of protein expression by eGFP
visualization for pUL47eGFP, as well as for enhanced expression of
pUL48 (Figs. 3–5), thus relieving the speculations on the possible
inexpediency of mAbs to tegument proteins to detect properly
their protein expression (Dorange et al., 2000).
A possible explanation for this differential expression could be
that the highly differentiated FFE cells afford a cellular environ-
ment that allows activation of viral promoters otherwise silent in
commonly used cell types. The identiﬁcation of a promoter region
for MDV pUL48 has not been reported and former reports on the
in vitro or in cellulo expression of UL49-UL48 RNA showed that
pUL48, in those conditions, could be translated from a bicistronic
RNA (Dorange et al., 2000; Koptidesova et al., 1995); however to a
reduced level compared to pUL49. Further studies are being
pursued to address potential promoter elements in highly differ-
entiated keratinocytes, focusing on the putative promoters of UL47
and UL48. Whether differential expression of viral proteins is a
common feature of herpesviruses or other viruses remains to be
determined. With respect to pUL47 homolog expression, VZV
appears to express detectable levels of pUL47 (Che et al., 2011),
as well as the related avian turkey herpesvirus (manuscript in
preparation); therefore the lack of pUL47 expression in vitro may
be unique to MDV.
Having established differential expression for pUL47 and
pUL48, we wished to gain greater insight over the causes of these
differences, building a rationale toward generating better assem-
bly of MDV virions in CEC cultures. When putative autologous
promoters were exchanged for PCMV, we observed signiﬁcant
increased expression of the pUL47 or pUL48, individually (Fig. 3).
In an earlier report, we showed that expression of pUL47eGFP
(vUL47eGFP) was very low and what could be detected was
predominantly nuclear in vitro, while it was localized mostly to
the cytoplasm in FFE cells of infected chickens (Jarosinski et al.,
2012). With increased expression of pUL47eGFP (vPCMVUL47eGFP),
the protein appeared to accumulate in the cytoplasm of infected
CEC cultures as seen in FFE cells for vUL47eGFP. Our results here
support this observation that pUL47eGFP is mostly nuclear when
expressed at low levels; however, with increased expression of
pUL47eGFP using vPCMVUL47eGFP (Figs. 3 and 4), there appeared
to be more cytoplasmic localization in vitro than previously seen
with vUL47eGFP (Fig. 1). Interestingly, the enhanced expression of
either pUL47 or pUL48 had no observable effect on MDV replica-
tion in vitro (Fig. 3). This was somewhat unexpected, since we
originally hypothesized that the low level expression of these
proteins may be related to the inefﬁcient replication and virion
assembly of MDV when grown in primary cell cultures in vitro. It is
well-established that many viral proteins act together to effec-
tively perform their functions. For example, pUL47 binds RNA and
shuttles RNA molecules between the cytoplasm and nucleus
(Donnelly and Elliott, 2001b) and the transcriptional activity of
pUL48 has been shown to be enhanced by pUL47 (Vittone et al.,
2005; Zhang and McKnight, 1993; Zhang et al., 1991). Thus,
without increased expression of both pUL47 and pUL48, the effects
would be predicted to be minimal. Interestingly, insertion of PCMV
upstream of UL47eGFP resulted in enhanced expression of both
pUL47eGFP and pUL48 (Fig. 6); however this result still did not
lead to an increase in in vitro replication (Fig. 3), nor production of
extracellular cell-free virus (Fig. 4).
Currently, it is not known why increased expression of
pUL47eGFP resulted in signiﬁcantly increased levels of pUL46
and pUL48 proteins as well. Insertion of PCMV upstream of UL47
resulted in increased transcription of UL46, UL47, UL48, and UL49
(Fig. 8), which could explain the enhanced protein expression of
pUL46 and pUL48, but it is not known why pUL49 levels were not
increased as well (Fig. 6). It has been previously shown that
promoters, such as PCMV, can have transcriptional effects on
proximal genes (Hampf and Gossen, 2007), which could explain
why all four genes were up-regulated by PCMV upstream of UL47.
However, if PCMV has such a high level of promoter crosstalk, then
why was only UL48 mRNA and pUL48 expression signiﬁcantly
increased by insertion of PCMV upstream of UL48? One potential
reason for these results could be the multiple functions ascribed to
pUL47 including its ability to bind RNA. It is thought that HSV-1
pUL47 shuttles RNA molecules between the cytoplasm and
nucleus (Donnelly and Elliott, 2001b) and recently has been shown
to also play a role in regulating selective degradation of mRNA by
the VHS RNase of HSV-1 (Shu et al., 2013). If MDV pUL47
performed a similar function, this could explain the increased
levels of UL46, UL47, UL48, and UL49 following signiﬁcantly
increased levels of pUL47 in cells and subsequently increased
levels of pUL46 and pUL48. However, it should be noted that these
functions involving interaction with, and shuttling of, RNA have
not been experimentally demonstrated for MDV pUL47.
One of the reasons for initiating our study was the hypothesis
that increased pUL48 expression in FFE could be linked to or
promote “complete” viral assembly, which may be down-regulated
in CEC cultures due of the lack of activation of endogenous
promoters. pUL48 is dispensable for MDV replication in vitro; there-
fore it was expected that plaque sizes were unaffected by increased
Fig. 4. Cell-free virus extraction of rVZV, rHVT, and rMDV. (A) Cell-free virus
extracts were collected from infected cultures of each respective virus and titrated
on the respective cell type used to generate cell-free virus. After 4–7 days pi, cells
were ﬁxed, stained, and plaques were counted. The average amount of cell-free
virus extracted from vMDV (RB1B) was signiﬁcantly lower when compared to vVZV
and vHVT in three independent experiments. Groups with different letters are
signiﬁcantly different using a Tukey–Kramer comparison of means (Pr0.05).
(B) Cell-free virus extracts were collected from infected cultures of each respective
virus and immediately titrated on CEC cultures. After 5–7 days pi, cells were ﬁxed,
stained, and plaques were counted. The average amount of cell-free virus extracted
from each group is shown with standard deviations and were not signiﬁcantly
different between the groups in three independent experiments using Student’s
t tests.
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pUL48 expression. MDV is strictly cell-associated during replication
in tissue culture and pUL48's function(s) during in vitro replication
are most likely small in contrast to other alphaherpesviruses in
which pUL48 has been shown to be essential. These viruses, such as
HSV-1 and PRV (Fuchs et al., 2002, 2003; Weinheimer et al., 1992),
replicate well in vitro and produce cell-free virus, thereby the
importance of pUL48 would be expected to be much greater. For
HSV-1 pUL48, it is well known that the protein is essential because
of its role in the egress of virions leading to the production of cell-
free virus rather than for its activation of IE genes (Mossman et al.,
2000; von Einem et al., 2006). An interesting comparison can be
made between MDV replication in CEC cultures and the HSV-1
8MAΔVP16 mutant virus, which is highly cell-associated in non-
complementing cells and produces no extracellular virions like MDV
(Weinheimer et al., 1992). Our results are not in favor of a unique
role for MDV pUL48 in viral egress, as increased protein expression
did not yield extracellular virus and increased viral replication. This
function is apparently not important for MDV and VZV (Che et al.,
2006; Dorange et al., 2002), another highly cell-associated alpha-
herpesvirus, replication in vitro. Though pUL48 is dispensable for
VZV replication in vitro, pUL48 is essential for proper virion forma-
tion and cell-to-cell spread in human skin cells (Che et al., 2006).
When referring to the role of pUL48 and pUL47 in viral
pathogenesis, although both are rated as “dispensable” for MDV
and VZV in cell culture (Che et al., 2008; Dorange et al., 2002),
their deletion in VZV yielded viruses that were strongly impaired
for replication and cell-to-cell spread in human skin cells (Che et
al., 2008, 2006). The impact on VZV virulence in skin that was
even more signiﬁcant when ORF11 (pUL47) was removed. The
importance of MDV late tegument proteins encoded by the gene
cluster UL46-UL49 has not been assessed in vivo so far, though
deletion of UL47 in the virulent RB-1B backbone yielded a fully
oncogenic virus (J.F Vautherot, unpublished observation). How-
ever, transmission from host-to-host could not be assessed as this
rMDV was generated on the backbone of the transmission-
deﬁcient RB-1B originally described (Petherbridge et al., 2004).
The low level of expression of pUL47 in infected T cells (Jarosinski
et al., 2012) suggest its importance in oncogenicity is minimal,
while its abundant expression in FFE cells indicates that pUL47
(and pUL48) are required for efﬁcient MDV replication and
dissemination, as shown for the VZV orthologues of these genes
(Che et al., 2008). MDV does not cause skin lesions but one could
hypothesize that, in MDV, both proteins play a major role in the
horizontal dissemination of virus, provided that an increased
expression is a marker of efﬁcient assembly in FFE cells. Similar
results have been shown for rMDV lacking UL44 (gC) or UL13
protein kinase activity that replicated and caused tumors in
chickens comparable to wild-type virus; however these viruses
were unable to transmit from chicken-to-chicken (Jarosinski et al.,
2007; Jarosinski and Osterrieder, 2010). In all, these data indicate
that, although being dispensable for cell-to-cell transmission
without affecting intrinsic pathogenicity of the viral mutants, such
structural proteins may be essential for host-to-host transmission.
The identiﬁcation of such genes could have a major impact on the
design of vaccinal viruses in the future that do not spread from
vaccinated to other individuals.
Fig. 5. Expression and localization of late tegument proteins in vitro and in situ. (A) CEC cultures were infected with vPCMVUL47eGFP (ICP4, pUL46, pUL47, and pUL49) or
vPCMVUL48 (pUL48) on glass coverslips and then ﬁxed at 5 days pi. Plaques were stained for speciﬁc MDV antigens. Visualization of pUL47eGFP (green) or speciﬁc MDV
antigens (red) are shown with Hoechst 33324 (blue). pUL47eGFP expression with each speciﬁc MDV antigen is also shown for co-localization studies. Shown are
representative infected cells of plaques at high magniﬁcation (Z630 ) for each viral protein examined. Regions of pUL49 and pUL47eGFP within the nucleus that were
exclusively not localized together are noted with white dots. (B) Skin/feather tissues were collected from vUL47eGFP-infected chickens at 21 days pi and slides with tissues
were ﬁxed and stained as in (A). Areas of obvious visual co-localization are noted with yellow arrows.
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Conclusion
In conclusion, we have shown in this report that proteins
encoded within the UL46-UL49 gene cluster of MDV are differen-
tially expressed when comparing in vitro cell culture propagation
to in situ replication in infected chickens. This differential expres-
sion was not necessarily directly related to lack of mRNA expres-
sion in vitro; however, increased expression of pUL47, but not
pUL48 by exchanging their respective putative promoter regions
for PCMV, resulted in increased mRNA and protein expression of all
four genes. These results suggest MDV pUL47 may play a role in
regulating their mRNA or protein levels, as has been suggested for
HSV-1. Although increased expression of pUL47 and pUL48 were
accomplished in vitro, no signiﬁcant difference in replication was
determined indicating those two viral factors are not solely
responsible for inefﬁcient virus assembly in vitro.
Materials and methods
Generation of high expression pUL47eGFP and pUL48 rMDV
Two-step Red-mediated mutagenesis (Tischer et al., 2010) was
used to replace the putative endogenous UL47 (PUL47) and UL48
(PUL48) promoters with PCMV using the rUL47eGFP BAC construct
previously described (Jarosinski et al., 2012). Brieﬂy, the PCMV-I-
SceI-aphAI cassette was ampliﬁed from pEP-CMV-in (Tischer et al.,
2006) and used for mutagenesis in GS1783 Escherichia coli cells.
Putative promoters were deﬁned by 50 untranslated regions for
UL47 and UL48 without overlapping with upstream ORFs for UL48
and UL49, respectively. All clones (rUL47eGFP, rPCMVUL47eGFP, and
rPCMVUL48) were conﬁrmed by RFLP analysis, analytic PCR, and
DNA sequencing. Oligonucleotides used for mutagenesis are
shown in Table S2.
Cell cultures and viruses
CEC cultures were prepared from 11-day-old speciﬁc-patho-
gen-free (SPF) embryos following standard methods (Schat and
Sellers, 2008) and maintained in minimal Eagle's media (MEM)
supplemented with 0.2–4% fetal bovine serum (FBS) and antibio-
tics (100 U/ml penicillin and 100 mg/ml streptomycin). DF-1-Cre
cells have been previously published (Niikura et al., 2011) and
were kindly provided by Masahiro Niikura (USDA-ARS-ADOL). DF-
1-Cre cells were grown in Leibovitz’s L-15 and McCoy 5A (LM)
media supplemented with 10% FBS and antibiotics (100 U/ml
penicillin and 100 mg/ml streptomycin), and maintained in 50 mg/
ml Zeocin. Human melanoma cells, MeWo (Grose et al., 1979),
were grown in Dulbecco’s modiﬁed Eagle’s medium supplemented
with 8% fetal bovine serum, nonessential amino acids, and
antibiotics.
Preparation of cell-associated viruses
rHVT (Baigent et al., 2006), a kind gift from Dr. Venugopal Nair
(The Pirbright Institute, UK) and rMDV were reconstituted by
transfecting DF-1-Cre cells, which efﬁciently removes the mini-F
sequences from the viral genome using ﬂanking loxP sites, then
passed into CEC cultures. rVZV was reconstituted by transfection
of MeWo cells using Lipofectamine 2000 (Life Technologies,
Fig. 6. Enhanced expression of pUL46 and pUL48 following increased expression of pUL47eGFP. CEC cultures were infected with vUL47eGFP, vPCMVUL47eGFP or vPCMVUL48
on glass coverslips and then ﬁxed at 5 days pi. Plaques were stained as described in Fig. 2 for pUL46 (A), pUL48 (B), and pUL49 (C) and ﬂuorescent signals were quantitated as
described in Materials and methods section. See Fig. S2 for representative images. Shown here are each respective protein’s percent signal relative to total MDV protein
expression. The percent expression for pUL46, pUL47, pUL48, and pUL49 of vPCMVUL47eGFP or vPCMVUL48 were compared to vUL47eGFP for each antigen and statistically
signiﬁcant differences (Po0.05) are indicated with an asterisk (*). (D) Western blot analysis for pUL47eGFP, pUL48, and pp38, as an infected culture control. Protein extracts
from CEC cultures (lane 1), vUL47eGFP (lane 2), vPCMVUL47eGFP (lane 3), and vPCMVUL48 (lane 4) were electrophoresed through a 12% SDS-PAGE gel, transferred to
nitrocellulose membranes, and probed for each speciﬁc antigen using antibodies described in Materials and methods section. Anti-GAPDH antibody was used as internal
cellular control, while anti-pp38 antibody was used as control for relative infection levels. Anti-pp38 H19 has been reported to recognize phosphorylated and non-
phosphorylated pp38, as well as pp24 antigens in MDV infected cultures (Cui et al., 1990). Two forms of pUL47eGFP can be seen in protein extracts collected from
vPCMVUL47eGFP, while pUL48 can be clearly seen up-regulated in both vPCMVUL47eGFP and vPCMVUL48 samples.
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Carlsbad, CA) as previously described (Tischer et al., 2007). This
VZV BAC clone encodes a self-excisable mini-F sequence. All
reconstituted viruses were used at r5 passages for in vitro and
in vivo studies.
Measurement of plaque areas
Plaque areas were measured as previously described (Jarosinski
et al., 2005). Brieﬂy, CEC cultures were seeded in 6-well dishes and
infected with 100 plaque forming units (PFU) of each virus per
well. After 5 days, cells were washed once with phosphate
buffered saline (PBS), ﬁxed and permeabilized with PFA buffer
(2% paraformaldehyde, 0.05% Triton X-100) for 15 min, and then
washed twice with PBS. IF assays were performed using anti-MDV
chicken sera and goat anti-chicken IgY-Alexa Fluor 568 secondary
antibody. Digital images of 30 individual plaques were obtained
using a Nikon Eclipse-Ti-E inverted ﬂuorescent microscope and
plaque areas were measured using ImageJ (Abramoff et al., 2004)
version 1.41o software (rsb.info.nih.gov/ij) and means were deter-
mined for each virus. Signiﬁcant differences in mean plaque areas
were determined using Student’s t tests.
Preparation of cell-free virus
Cell-free virus was prepared similarly to previously published
studies (Grose et al., 1979), but modiﬁed for these studies. Brieﬂy,
75 cm2 ﬂasks were infected with 10,000 PFU of cell-associated
virus and at 85–95% cytopathic effect (CPE), media was removed
from the cells and ﬂoating cells were pelleted by centrifugation at
1500 g for 5 min. Media supernatant was transferred to a new
tube for later use. Five milliliters of SPA buffer (7.5% sucrose in
0.01 M NaPO4 and 1.0% bovine serum albumin) was added to each
ﬂask and cells were dislodged with a rubber policeman and
combined with pelleted cells from above, then sonically disrupted
at 20 Hz for 10 s using a W-220 sonicator from Heat Systems-
Ultrasonic, Inc. on ice. The samples were centrifuged at 300 g to
remove cellular debris from the supernatant. Two-fold dilutions of
fresh cell-free virus extract was added to CEC cultures or MeWo
cells in 24 or 6-well plates starting at 1:8 dilutions. Cells were
incubated with diluted cell-free virus extracts for 2 h at 37 1C after
which cell-free virus extract media was removed and fresh media
was added to cells. After 4–8 days, indirect IF assays described
above were used to count plaques.
Indirect IF assays
CEC cultures or MeWo cells were infected with viruses in
6-well dishes at 100 PFU per well. At 4 (HVT) or 5 (VZV and
MDV) days pi, cells were ﬁxed and permeabilized with PFA buffer
for 15 min and then washed twice with PBS. Infected cells used for
antigen detection were blocked in 10% fetal bovine serum and
stained with the following antibodies: Polyclonal anti-MDV/HVT
chicken sera were used for HVT and MDV (Jarosinski et al., 2007)
and mAb anti-VZV IE62 (Santos et al., 2000) was used for VZV.
Secondary antibodies used included goat anti-chicken IgY-Alexa
Fluors 488 or 568 and goat anti-mouse IgG-Alexa Fluors 488 or
Fig. 7. RT-qPCR analysis of MDV UL46-UL49 locus gene expression in vitro and in situ. (A) Schematic representation of the genomic structure of MDV showing the locations of
the TRL, TRS, UL, US, IRL, and IRS regions. It has been previously shown that multiple transcripts are produced from this locus during in vitro replication (Yanagida et al., 1993)
and these transcripts are shown here, including locations of primers used in this study for RT-qPCR. (B) Transcripts for UL46, UL47, UL48, UL49, and ICP4 were quantiﬁed
from total RNA extracted from vUL47eGFP-infected CEC cultures over 6 days. The mean number of transcripts per 103 GAPDH transcripts from three separate wells for each
group at 24 h intervals are shown with standard deviations. (C) Transcripts from UL46, UL47, UL48, UL49, and ICP4 were quantiﬁed from total RNA collected from three
individual feather follicles infected with vUL47eGFP. Shown is the mean number of transcripts per 103copies of GAPDH with standard deviations. No statistics were
performed on these data.
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568 (Molecular Probes, Eugene, OR). Hoechst 33342 (2 mg/ml,
Molecular Probes) was used to visualize nuclei. All images were
compiled using Adobes Photoshops CS2 version 9.0.2.
Western blot analysis
Western blot analyses were performed essentially as previously
described (Tischer et al., 2005). To detect MDV proteins, mAb
against pUL48 (Dorange et al., 2000) was used at 1:500 dilution
and H19 (Lee et al., 1983) was used at 1:10,000 dilution to detect
MDV pp38 protein. For protein loading controls, anti-chGAPDH
(GA1R, Thermo Scientiﬁc, Rockford, IL) or anti-Actin (ACTNO5;
Abcams, Cambridge, MA) mAbs were used at their recommended
dilutions. Secondary anti-mouse IgG-peroxidase conjugate was
purchased from GE Healthcare (Piscataway, NJ). To detect
pUL47eGFP, goat anti-eGFP antibody (ab111258; Abcams) was
used with secondary donkey anti-goat IgG-horseradish peroxidase
conjugate (A16005; Life Technologies).
Northern blot analysis
Total RNA was extracted from uninfected or rMDV-infected CEC
cultures in 75 cm2 tissue culture ﬂasks using RNA STAT-60 (Tel-
Test, Inc., Friendship, TX) according to the manufacturer’s instruc-
tions. Fifteen micrograms of RNA from each sample was electro-
phoresed in a 0.9% denaturing formaldehyde agarose gel then
transferred to a nylon membrane (GE Healthcare). The RNA was
hybridized with DIG-labeled DNA probes for UL46, UL47, UL48,
and UL49 in DIG Easy Hyb Buffer (Roche Applied Science, Madison,
WI). DIG-labeled probes were generated using the PCR DIG Probe
Synthesis Kit from Roche Applied Science using the manufacturer’s
instructions and primers shown in Fig. S3 and Table S1. Anti-DIG-AP
Fig. 8. RT-qPCR analysis of MDV UL46-UL49 locus gene expression following increased expression of pUL47eGFP or pUL48. Speciﬁc gene transcripts were quantiﬁed using
total RNA collected from vUL47eGFP-, vPCMVUL47eGFP-, or vPCMVUL48-infected CEC cultures every 24 h for 6 days. Shown is the average copies determined for three
experiments showing the number of transcripts for (A) ICP4, (B) UL44, (C) UL46, (D) UL47, (E) UL48, and (F) UL49 per 103 GAPDH transcripts over the course of 6 days.
Statistically signiﬁcant differences (Po0.05) for vPCMVUL47eGFP- or vPCMVUL48-infected CEC cultures are indicated with an asterisk (*) compared to vUL47eGFP-infected CEC
cultures.
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Fag fragments were used to detect hybridized DIG-labeled probes
with ready-to-use CDP-Star chemiluminescent substrate (Roche
Applied Science).
Laser scanning confocal microscopy
CEC cultures were infected with vUL47eGFP, vPCMVUL47eGFP,
or vPCMVUL48 on sterile glass coverslips in 24-well dishes at 50
PFU per well. At 4 days pi, cells were ﬁxed and permeabilized with
PFA buffer for 15 min and then washed twice with PBS. Skin/
feather tissues were collected from MDV-infected chickens and
snap-frozen in Tissue Teks-optimal cutting temperature (OCT)
compound (Sankuras Finetek, Torrance, CA) and stored at 80 1C
until sectioned. Eight micrometer sections were afﬁxed to Super-
frost/Plus slides (Fisher Scientiﬁc, Pittsburgh, PA) and ﬁxed as
described above.
Infected CEC cultures and cryosectioned tissues used for antigen
detection were blocked in 10% FBS, then stained with chicken anti-
MDV polyclonal sera (Jarosinski et al., 2005) and mAbs speciﬁc for
MDV ICP4 (Blondeau et al., 2007), pUL46 (Dorange et al., 2002),
pUL47 (Dorange et al., 2002), pUL48 (Dorange et al., 2000), or pUL49
(Dorange et al., 2000). Goat anti-chicken IgY-Alexa Fluor 633 and
anti-mouse IgG-Alexa Fluor 568 (Molecular Probes, Eugene, OR)
were used as secondary antibodies. Hoechst 33342 (2 mg/ml, Mole-
cular Probes) was used to visualize nuclei. For each antigen analyzed,
the maximum signal was determined and then the gainwas dropped
in order to ensure signals were not saturated. In order to compare to
previously published results, vUL47eGFP was used to observe pUL47
expression in conjunction with other viral proteins. The confocal
images of infected cells were collected using an upright Zeiss LSM-
710 Spectral confocal microscope using a 20 objective lens. Image
size was set to 10241024 pixels. Multi-track sequential acquisition
settings were used to avoid inter-channel cross-talk. Optimized
emission detection bandwidths were conﬁgured by Zeiss Zen control
software. The confocal pinhole was set to 1 Airyunit. The following
ﬂuorescent dyes were excited and emissions detected: Hoechst
33343 excited at 405 nm with a diode laser and detected at 417–
450 nm; eGFP excited with a multiline Argon laser (488 nm laser)
and detected at 498–550 nm; Alexa Fluor 568 excited at 561 nm
with a diode-pump solid state (DPSS) laser and detected at 566–
632 nm; Alexa Fluor 633 excited at 633 nm with a Helium–Neon
laser and detected at 652–711 nm. For collection of images used for
quantitative analysis, criteria were adjusted for optimal accuracy and
precision based on Waters (Waters, 2009). For each speciﬁc viral
protein examined, Alexa 568 signals were adjusted such that the
threshold was set below saturation levels without having signiﬁcant
background from uninfected cells. Infected cells were determined
using signal generated from the anti-MDV polyclonal sera (Alexa
633). For analysis of expression of pUL47eGFP and pUL48, para-
meters were set for overexpression with rPCMVUL47eGFP and
vPCMVUL48 viruses. For quantiﬁcation of signals, the arithmetic mean
intensity for each channel was used and the average of three images
was calculated. Speciﬁc viral protein signals were normalized to total
MDV protein signals. All images were compiled using Adobes
Photoshops CS2 version 9.0.2.
RT-qPCR analysis
Total RNA was collected from MDV-infected CEC cultures in
25 cm2 tissue culture ﬂasks using TRI Reagents RT (Molecular
Research Center, Inc., Cincinnati, OH) according to the manufacturer’s
instructions. For collection of RNA from infected FFE cells, wing
feathers were plucked from vUL47eGFP-infected chickens at 21 days
pi and placed in RNAlaters Solution (Life Technologies) until
processed. UL47eGFP positive FFE cells were visualized using an
Olympus SZX-12 Stereoscope with the green ﬁlter cube, collected
using sterile forceps, and RNA was extracted using TRI Reagents RT
according to the manufacturer’s instructions.
RT was performed as a large batch with 5 μg of total RNA using
the High Capacity cDNA Reverse Transcription Kit (Life Technolo-
gies). Two-hundred microliter reactions were carried out accord-
ing to the manufacturer’s instructions with RNase Inhibitor and
poly(T) primers. The reaction mixture was incubated at 25 1C for
10 min, then 37 1C for 120 min, followed by 85 1C for 5 min. To
amplify cDNA, Power SYBRs Green PCR Master Mix (2 ) was
used. Brieﬂy, 5 μl of the RT mixture was used in 20 ml volumes
containing 50 mM speciﬁc viral gene or chGAPDH forward and
reverse primers (Table S1). Each primer set was designed using the
NCBI/Primer-BLAST program (Ye et al., 2012) with parameters of
100 to 300 nt for Product Length, 6073 1C for OptimalTm, and
Gallus for Organism, and tested for speciﬁcity using qPCR assay
parameters and PCR products were gel puriﬁed and sequenced to
conﬁrm speciﬁcity (data not shown).
For the generation of standard curves in RT-qPCR assays, a
plasmid containing chGAPDH (Jarosinski et al., 2003) and a BAC
clone containing the complete MDV genome were used (Jarosinski
et al., 2007). Serial 10-fold dilutions of each respective plasmid or
BAC were used for generating standard curves, starting with
approximately 500 pg of DNA. Total copy numbers were deter-
mined as previously described (Jarosinski et al., 2002), and
standard curves were generated by plotting the threshold cycle
(CT) value at each dilution with the total copies. The coefﬁcient of
regression was always 40.98 for standard curves. Quantiﬁcation
of MDV speciﬁc transcripts were performed using primers speciﬁc
for the each respective MDV transcript and chGAPDH as a normal-
izing control. Thermal cycling conditions were as follows: 95 1C for
20 s, followed by 40 cycles at 95 1C for 3 s and 60 1C for 30 s. All
RT-qPCR assays were performed in an ABI Prism 7300 Real-time
PCR System (Applied Biosystems) and the results were analyzed
using Sequence Detection Systems version 1.4.0 software supplied
by the manufacturer.
In vivo experiments
Commercial SPF White Leghorn chickens were obtained from
Hy-Line Internationals (Dallas Center, Iowa) and were from MDV-
vaccinated parents and therefore considered to be maternal anti-
body positive (Abþ). All experimental procedures were conducted
in compliance with an approved Institutional Animal Care and Use
Committee protocol (University of Iowa protocol #1109207). Water
and food were provided ad libitum. One-day old chicks were
inoculated intra-abdominally with 2,000 PFU of vUL47eGFP and
skin/feather tissue samples were collected at 21 days pi.
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